Akili, Inc. - Common Stock (AKLI)

$0.24 0.0045 (1.81%)

15:58 EDT AKLI Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Mar 27, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news!

Why Is Akili (AKLI) Stock Up 110% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 22,803

Day's Range $0.23 - $0.25

52-Week Range $0.19 - $1.67

Dividend & Yield N/A (N/A)

AKLI Stock Predictions, Articles, and Akili, Inc. - Common Stock News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jun 9, 2023

It's time for a final look at the biggest pre-market stock movers this week as we check out what's happening on Friday morning!

Why Is Akili (AKLI) Stock Up 21% Today?

By William White, InvestorPlace Writer May 3, 2023

Akili (AKLI) stock is gaining on Wednesday after the company's video game treatment showed success in reducing ADHD in adults.

DNAA Stock Races 200% Higher as Akili SPAC Merger Closes

By Dana Blankenhorn, InvestorPlace Contributor Aug 22, 2022

DNAA becomes AKLI when trading opens Aug. 22, and hopes are high for EndeavorRX, its video game treatment of ADHD.

Akili's ADHD device submitted for Japanese approval, stock rallies 130% (NASDAQ:AKLI)

From Seeking Alpha Feb 26, 2024

Akili (AKLI) stock rallied 130% Monday on news that partner Shionogi has submitted an application for Japanese regulatory approval of its digital therapeutic SDT-001 for ADHD.

Akili said CEO Eddie Martucci has been appointed chair (NASDAQ:AKLI)

From Seeking Alpha Oct 6, 2023

Akili announces leadership transition with Eddie Martucci as chair and Matt Franklin as president and CEO.

Akili to cut down ~40% workforce as it focuses on non-prescription model (NASDAQ:AKLI)

From Seeking Alpha Sep 13, 2023

Akili (AKLI) said on Wednesday that it will cut down its workforce by ~40% as it looks to transition from prescription to a non-prescription business model. The reduction in staff...

Akili stock rises after video game EndeavorRx shows benefit in ADHD adults

From Seeking Alpha May 3, 2023

Akili (AKLI) stock rose after the company reported results from a trial of video game EndeavorRx to treat adults with ADHD. Read more here

Down More Than 50%: These 3 “Strong Buy” Stocks Are Too Cheap to Ignore

From TipRanks Nov 1, 2022

With the Federal Reserve holding its November FOMC meeting now, there’s plenty of speculation on the central bank’s next move. The conventional wisdom says the Fed ...

ADVERTISEMENT